California Firm Uses Biotech Corn to Develop Hepatitis B Vaccine
John Howard, founder of Applied Biotechnology Institute, is experimenting with biotech corn to develop affordable, and easy-to-administer vaccine for hepatitis B. According to Howard, the goal of his company is to produce oral vaccine in a form of wafer, which would be cheaper compared to other vaccines, and would not need cold storage.
"If we are successful in this, it could be a really big deal," Howard said. "A small farm could vaccinate the world."
This article is part of the Crop Biotech Update, a weekly summary of world developments in agri-biotech for developing countries, produced by the Global Knowledge Center on Crop Biotechnology, International Service for the Aquisition of Agri-Biotech Applications SEAsiaCenter (ISAAA)